Clinical Trials · NCT01387347
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- ReGenTree, LLC
- Enrollment
- 72
- Start date
- Aug 2011
- Locations
- See registry
- Primary endpoint
- Corneal Staining (Inferior Region) in the Worst Eye in the Controlled Adverse Environment (CAE) Model, Which is a Regulated Environmental Setting Aimed at Exacerbating the Signs and Symptoms of Dry Eye